Gensco® Pharma’s abilities provide boundless possibilities for improving health utilizing our unique preparations, innovative dosing methods, and proprietary drug delivery technologies.
Gensco® Pharma has developed and patented a unique transdermal drug delivery system... read more
Gensco® Pharma’s patented topical metered dose applicator dispenses an exact and consistent dose of medication with every pump... read more
Prepare for the flare with the first transdermal treatment for gout flares... read more
The first FDA-approved prescription combination drug-device hydrogel containing Lidocaine 4% HCl for associated pain, wound healing and vasculitis.... read more
Delivers fast controlled pain relief at the site... read more
Non-NSAID alternative for pain, inflammation and bruising. Targeting the source of pain... faster... read more
- April 23 - April 28
- April 27 - April 28
- April 30 - May 3
- May 1 - May 4
- May 16 - May 18
Looking To The Future
- The Difference Between Topical and Transdermal Medications March 29, 2017 Clinical, Research - White Paper by Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs, Gensco Pharma Abstract more...
- Advances in Treatment of Painful Wounds November 28, 2016 Articles, Clinical, Featured - by Marc Alan Brenner, DPM, The Institute for Diabetic Foot Research As seen in Podiatry Management more...
- Gensco’s Astero hydrogel alleviates diabetic foot ulcers November 21, 2016 Articles, Clinical - As seen in Chain Drug Review's Diabetes Care Report. Approximately 15% of people with diabetes more...
- A Review and Case Study of Astero® (Lidocaine HCl 4%), a New Prescription Hydrogel for Painful Wounds November 16, 2016 Articles, Clinical, Featured - By Marc A. Brenner, DPM | Podiatry Management, Clinical Innovations, The Diabetic Foot. Wound pain more...